 |
|
|
|
 |
|
|
|
| Article 1 to 10 out of 92
|
|
-
Micronit Microfluidics Receives Grant
(15 Apr 2008)
EUR 1.2M Funding from Government and Province
Micronit Microfluidics has been granted EUR 1.2M within High Tech Factory. High Tech Factory is a joint initiative of microsystems and nanotechnology companies around MESA+ Institute for Nanotechnology of the University of Twente. Micronit, ......
-
PanGenetics raises 23 million Euro in a series C financing to fund clinical advancement of its therapeutic antibody programs
(07 Mar 2008)
PanGenetics B.V. announced that the company has closed a series C financing round in which it raised a total of 23 million Euro (US$34 million). The round was led by Edmond de Rothschild Investment Partners (EdRIP), with participation from ......
-
Progentix Orthobiology B.V. closes Series A financing round
(24 Jan 2008)
Progentix Orthobiology B.V. announced the closure of its Series A financing Round. The round was led by BioGeneration Ventures. Progentix Orthobiology B.V. was established in 2007 and develops a unique suite of osteoinductive material products ......
-
Galapagos awarded EUR4.4 M grant for rheumatoid arthritis drug development
(18 Jan 2008)
Galapagos NV announced that it has been awarded a EUR 4.4 M grant from the Flanders government through the Institute for the Promotion of Innovation by Science and Technology (IWT). The three-year project entitled "Kinases in Inflammation" aims ......
-
Protagen raises EUR 1 million to expand its protein biochips business unit
(17 Jan 2008)
Protagen AG announced the closing of an interim financing round. The EUR 1 million raised will be used to expand the company's protein biochips business unit. The capital raised in this round has come from the existing institutional investors, ......
-
Novacta receives £3.5 million strategic translation award from the Wellcome trust ot target C. difficile infections
(16 Jan 2008)
Novacta Biosystems, a UK-based anti-infective therapeutics company, announced that the Wellcome Trust, the UK's largest medical research charity, has awarded it £3.5 million as part of the Trust's Strategic Translational Award programme. ......
-
Peptide Synthesis Company Activotec completes new funding round
(14 Jan 2008)
UK-based peptide synthesis technology company, Activotec, has just completed a significant funding round to enable it to further accelerate the growth of its business. Reflecting the solid growth achieved by the company over the last few years ......
-
Peakdale Molecular Announces GBP 1 Million Funding to Support Expansion and Growth
(11 Jan 2008)
Peakdale Molecular Ltd has announced that they have successfully completed a GBP1m round of equity funding which will enable Peakdale to continue the expansion of its facilities in the UK to support its continued rapid growth. The investors in ......
-
Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis
(11 Jan 2008)
Evotec AG provided further details on its planned NASDAQ listing in the context of the anticipated acquisition of Renovis Inc. Evotec AG has filed a registration statement on Form F-4 to register with the US Securities and Exchange Commission ......
-
Abcellute secures additional £400K funding to refine preservation technology and initiate cell therapy programme
(11 Dec 2007)
Abcellute, the Cardiff University spin-out, has announced a major injection of funds which will enable it to accelerate its cell therapy programme based on the company's unique non-freezing cell preservation technology. The £400K means that a ......
|
|
|
Top